Your browser doesn't support javascript.
loading
ARIA in patients treated with lecanemab (BAN2401) in a phase 2 study in early Alzheimer's disease.
Honig, Lawrence S; Barakos, Jerome; Dhadda, Shobha; Kanekiyo, Michio; Reyderman, Larisa; Irizarry, Michael; Kramer, Lynn D; Swanson, Chad J; Sabbagh, Marwan.
Affiliation
  • Honig LS; Department of Neurology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain Columbia University Irving Medical Center New York New York USA.
  • Barakos J; California Pacific Medical Center San Francisco California USA.
  • Dhadda S; Clario Inc. San Mateo California USA.
  • Kanekiyo M; Alzheimer's Disease and Brain Health Eisai Inc. Nutley New Jersey USA.
  • Reyderman L; Alzheimer's Disease and Brain Health Eisai Inc. Nutley New Jersey USA.
  • Irizarry M; Alzheimer's Disease and Brain Health Eisai Inc. Nutley New Jersey USA.
  • Kramer LD; Alzheimer's Disease and Brain Health Eisai Inc. Nutley New Jersey USA.
  • Swanson CJ; Alzheimer's Disease and Brain Health Eisai Inc. Nutley New Jersey USA.
  • Sabbagh M; Alzheimer's Disease and Brain Health Eisai Inc. Nutley New Jersey USA.
Alzheimers Dement (N Y) ; 9(1): e12377, 2023.
Article in En | MEDLINE | ID: mdl-36949897
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Alzheimers Dement (N Y) Year: 2023 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: Alzheimers Dement (N Y) Year: 2023 Document type: Article Country of publication: Estados Unidos